Patents by Inventor Peter Simmons

Peter Simmons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9668997
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: June 6, 2017
    Assignee: ALLERGAN, INC.
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20160328908
    Abstract: A compositing apparatus is provided that has, in certain implementations, electronic circuitry for combining visual content for an electronic game of chance. The compositing apparatus may receive wagering display information from a wagering engine that controls wagering aspects of the game and entertainment display information from an entertainment engine that controls non-wagering aspects of the game. The compositing apparatus may combine the wagering and entertainment display information for presentation to a player on a display. In certain implementations, the compositing apparatus also enables the wagering engine to control the output of display information on the display.
    Type: Application
    Filed: July 15, 2016
    Publication date: November 10, 2016
    Inventors: Richard Morgan, John Paul Mendocha, Steve Gourley, Peter Simmons
  • Publication number: 20160256424
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Application
    Filed: January 4, 2016
    Publication date: September 8, 2016
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20160235780
    Abstract: Embodiments described herein relate to formulations for and methods of use for eye drop formulations comprising carboxymethyl cellulose (CMC) and hyaluronic acid (HA) with an improved distribution on the cornea during blinking.
    Type: Application
    Filed: April 27, 2016
    Publication date: August 18, 2016
    Inventors: Bereth J. Beard, Wendy Blanda, David Marsh, Joseph G. Vehige, Peter Simmons, Haixia Liu, Steven Matsumoto
  • Publication number: 20160237169
    Abstract: The present invention relates to immunoglobulin new antigen receptors (IgNARs) from fish and uses thereof. In particular, the present invention relates to modified IgNAR variable domains and to domains from members of the immunoglobulin superfamily that have been modified to include structural features derived from IgNAR variable domains.
    Type: Application
    Filed: February 16, 2016
    Publication date: August 18, 2016
    Inventors: Stewart Nuttall, Victor Streltsov, Katherine Merne Griffiths, Jennifer Ann Carmichael, Peter Hudson, Robert Alexander Irving, Joseph Noozhumurry Varghese, Miles Mackay Barraclough, David Peter Simmons, Kylie Anne Henderson
  • Publication number: 20160199428
    Abstract: Provided herein are low salt ophthalmic pharmaceutical composition and methods of use thereof, for example, in the treatment of dry eye syndrome.
    Type: Application
    Filed: March 23, 2016
    Publication date: July 14, 2016
    Inventors: Peter A. Simmons, Joseph G. Vehige
  • Patent number: 9314528
    Abstract: Provided herein are low salt ophthalmic pharmaceutical composition and methods of use thereof, for example, in the treatment of dry eye syndrome.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: April 19, 2016
    Assignee: ALLERGAN, INC.
    Inventors: Joseph G. Vehige, Peter A. Simmons
  • Patent number: 9254324
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Grant
    Filed: April 8, 2014
    Date of Patent: February 9, 2016
    Assignee: Allergan, Inc.
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20150379803
    Abstract: A compositing apparatus is provided that has, in certain implementations, electronic circuitry for combining visual content for an electronic game of chance. The compositing apparatus may receive wagering display information from a wagering engine that controls wagering aspects of the game and entertainment display information from an entertainment engine that controls non-wagering aspects of the game. The compositing apparatus may combine the wagering and entertainment display information for presentation to a player on a display. In certain implementations, the compositing apparatus also enables the wagering engine to control the output of display information on the display.
    Type: Application
    Filed: September 3, 2015
    Publication date: December 31, 2015
    Inventors: Richard Morgan, John Paul Mendocha, Steve Gourley, Peter Simmons
  • Publication number: 20150196582
    Abstract: The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.
    Type: Application
    Filed: January 21, 2015
    Publication date: July 16, 2015
    Inventors: Joseph G. Vehige, Peter A. Simmons
  • Publication number: 20150050975
    Abstract: A compositing apparatus is provided that has, in certain implementations, electronic circuitry for combining visual content for an electronic game of chance. The compositing apparatus may receive wagering display information from a wagering engine that controls wagering aspects of the game and entertainment display information from an entertainment engine that controls non-wagering aspects of the game. The compositing apparatus may combine the wagering and entertainment display information for presentation to a player on a display. In certain implementations, the compositing apparatus also enables the wagering engine to control the output of display information on the display.
    Type: Application
    Filed: May 22, 2014
    Publication date: February 19, 2015
    Applicant: ACME EMBEDDED SOLUTIONS INC.
    Inventors: Richard Morgan, John Paul Mendocha, Steve Gourley, Peter Simmons
  • Patent number: 8957048
    Abstract: The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.
    Type: Grant
    Filed: October 4, 2012
    Date of Patent: February 17, 2015
    Assignee: Allergan, Inc.
    Inventors: Joseph G. Vehige, Peter A. Simmons
  • Publication number: 20140256675
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Application
    Filed: April 8, 2014
    Publication date: September 11, 2014
    Applicant: Allergan, Inc.
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20140242022
    Abstract: The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.
    Type: Application
    Filed: October 5, 2012
    Publication date: August 28, 2014
    Inventors: Joseph G. Vehige, Peter A. Simmons
  • Publication number: 20140221309
    Abstract: Embodiments described herein relate to formulations for and methods of use for eye drop formulations comprising carboxymethyl cellulose (CMC) and hyaluronic acid (HA) with an improved distribution on the cornea during blinking.
    Type: Application
    Filed: February 3, 2014
    Publication date: August 7, 2014
    Applicant: ALLERGAN, INC.
    Inventors: Bereth J. Beard, Wendy Blanda, David Marsh, Joseph G. Vehige, Peter Simmons, Haixia Liu, Steven Matsumoto
  • Patent number: 8753203
    Abstract: A compositing apparatus is provided that has, in certain implementations, electronic circuitry for combining visual content for an electronic game of chance. The compositing apparatus may receive wagering display information from a wagering engine that controls wagering aspects of the game and entertainment display information from an entertainment engine that controls non-wagering aspects of the game. The compositing apparatus may combine the wagering and entertainment display information for presentation to a player on a display. In certain implementations, the compositing apparatus also enables the wagering engine to control the output of display information on the display.
    Type: Grant
    Filed: February 6, 2012
    Date of Patent: June 17, 2014
    Assignee: Acme Embedded Solutions, Inc.
    Inventors: Richard Morgan, John Paul Mendocha, Steve Gourley, Peter Simmons
  • Patent number: 8729125
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Grant
    Filed: September 11, 2013
    Date of Patent: May 20, 2014
    Assignee: Allergan, Inc.
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20140045939
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Application
    Filed: September 11, 2013
    Publication date: February 13, 2014
    Applicant: Allergan, Inc.
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20140045773
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Application
    Filed: September 11, 2013
    Publication date: February 13, 2014
    Applicant: Allergan, Inc.
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Patent number: 8569370
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: October 29, 2013
    Assignee: Allergan, Inc.
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin